Ratings OrganoClick AB

Equities

ORGC

SE0006510335

Market Closed - Nasdaq Stockholm Other stock markets 08:06:41 10/05/2024 pm IST			5-day change	1st Jan Change
3.05 ^SEK	0.00%		-7.58%	-4.09%

30/04	OrganoClick AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
23/04	OrganoWood AB Announces Three-Year Results from the Field Study EN 12037 for Organowood Nowa	CI

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
The company has a poor ESG score according to Refinitiv, which ranks companies by sector.

Strengths

For several months, analysts have been revising their EPS estimates roughly upwards.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company appears highly valued given the size of its balance sheet.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
ORGANOCLICK AB	-4.09%	27.57M	D+
SIKA AG	+1.61%	49.2B	A-
GIVAUDAN SA	+16.33%	41.24B	B+
FUJIFILM HOLDINGS CORPORATION	+18.68%	25.89B	A-
EMS-CHEMIE HOLDING AG	+12.78%	19.81B	C+
CELANESE CORPORATION	+0.85%	17.48B	B+
POSCO FUTURE M CO., LTD.	-21.87%	15.86B	A-
SYMRISE AG	+2.32%	15.35B	B+
ALBEMARLE CORPORATION	-10.29%	15.23B	C+
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-22.30%	13.36B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders